Belvedere Trading
CORZ icon

Belvedere Trading’s Core Scientific CORZ Stock Holding History

Belvedere Trading’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,256
Closed -$62.6K – 733
2024
Q1 		$43.4K Buy
+12,256
New +$42.5K ﹤0.01% 517

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $508M AUM 83.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Belvedere Trading's CORZ Position: Q2 2024 in Review

Belvedere Trading sold out of Core Scientific (CORZ) in Q2 2024, closing a stake of 12,256 shares — an estimated $62.6K sold.

Belvedere Trading first reported a position in CORZ in Q1 2024 and held it in 1 quarter. The position peaked at $43.4K in Q1 2024. 189 funds tracked by Wall St. Rank hold CORZ as of Q2 2024.

  • Belvedere Trading reported no remaining Core Scientific position as of Q2 2024 after selling out during the quarter.
  • Belvedere Trading sold 12,256 Core Scientific shares in Q2 2024, an estimated $62.6K.
  • Belvedere Trading first reported a position in Core Scientific in Q1 2024 and held it in 1 quarter.
  • Belvedere Trading's Core Scientific position peaked at $43.4K in Q1 2024.
  • 189 funds tracked by Wall St. Rank held Core Scientific as of Q2 2024.

Based on Belvedere Trading's 13F filing for Q2 2024, filed 9 Aug 2024.